Journal of Research & Innovation in Anesthesia

Register      Login

VOLUME 3 , ISSUE 1 ( 2018 ) > List of Articles

CASE REPORT

Anesthesia Management of Simultaneous Cesarean Section and Valve Replacement: A Tight-rope Walk Twice!

Shakuntala Basantwani, Bharati A Tendolkar, Ruchi A Jain, Surabhi Nellore

Keywords : Anesthesia, Aortic stenosis, Cesarean section, Mitral stenosis, Rheumatic heart disease.

Citation Information : Basantwani S, Tendolkar BA, Jain RA, Nellore S. Anesthesia Management of Simultaneous Cesarean Section and Valve Replacement: A Tight-rope Walk Twice!. Res Inno in Anesth 2018; 3 (1):22-25.

DOI: 10.5005/jp-journals-10049-0043

License: CC BY-SA 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Rheumatic valvular stenosis is the most common valvular heart disease which is encountered in pregnant patients in our country. Combination of severe mitral or aortic stenosis (AS) and physiological changes that accompany pregnancy amplifies problems. Case report: Two patients with severe rheumatic valve stenosis underwent simultaneous cesarean section (CS) and valve replacement (VR) surgeries. Heart rate (HR) control with diltiazem was required in one patient who was in atrial fibrillation (AF). Anesthesia was induced with etomidate and rocuronium. Cesarean section was performed followed by VR. Conclusion and clinical significance: Management of anesthesia for such cases is a challenge, as there is a risk of worsening cardiac failure at multiple stages, increasing maternal and fetal morbidity and mortality. The conventional high-dose opioid-based anesthesia strategy followed for VR in stenotic lesions may cause neonatal respiratory depression requiring ventilatory support. A tight balance between maintaining maternal hemodynamics, uterine blood flow, and fetal oxygenation is required for good maternal and fetal outcomes.


PDF Share
  1. Hiralal K, Snehamay C. Pregnancy complicated by maternal heart disease: a review of 281 women. J Obstet Gynecol India 2012 May-Jun;62(3):301-306.
  2. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001 Jul;104(5):515-521.
  3. Bhatla N, Lal S, Behera G, Kriplani A, Mittal S, Agarwal N, Talwar KK. Cardiac disease in pregnancy. Int J Gynecol Obstet 2003 Aug;82(2):153-159.
  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 2014 Jun;63(22):2438-2488.
  5. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM); Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011 Dec;32(24):3147-3197.
  6. Born D, Martinez EE, Almeida PA, Santos DV, Carvalho AC, Moron AF, Miyasaki CH, Moraes SD, Ambrose JA. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J 1992 Aug;124(2):413-417.
  7. Cacciotti L, Passaseo I. Management of atrial fibrillation in pregnancy. J Atr Fibrillation 2010 Oct;3(3):295.
  8. Orme RM, Grange CS, Ainsworth QP, Grebenik CR. General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases. Int J Obstet Anesth 2004 Jul;13(3):183-187.
  9. Frölich MA, Burchfield DJ, Euliano TY, Caton D. A single dose of fentanyl and midazolam prior to Cesarean section have no adverse neonatal effects. Can J Anaesth 2006 Jan;53(1):79-85.
  10. Datt V, Tempe DK, Virmani S, Datta D, Garg M, Banerjee A, Tomar AS. Anesthetic management for emergency cesarean section and aortic valve replacement in a parturient with severe bicuspid aortic valve stenosis and congestive heart failure. Ann Card Anaesth 2010 Jan-Apr;13(1):64-68.
  11. Birincioglu CL, Küçüker SA, Yapar EG, Yildiz U lku, Ulus AT, Yamak B, Katircioglu SF, Tasdemir O. Perinatal mitral valve interventions: a report of 10 cases. Ann Thorac Surg 1999 May;67(5):1312-1314.
  12. Tempe DK, Virmani S, Tempe A, Sharma JB, Datt V, Nigam M. Anaesthetic management of emergency caesarean section and reoperative mitral valve replacement in a 32 weeks parturient: a case report. Ann Card Anaesth 2002 Jan;5(1):63-67.
  13. Bilehjani E, Kianfar AA, Toofan M, Fakhari MS. Anesthesia with etomidate and remifentanil for cesarean section in severe peripartum cardiomyopathy. Middle East J Anesthesiol 2008 Jun;19(5):1141-1149.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.